These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 22612537)
1. Modifying T-cell trafficking to the intestinal as a potential management for inflammatory bowel disease. Lawrance IC Expert Opin Investig Drugs; 2012 Jul; 21(7):975-84. PubMed ID: 22612537 [TBL] [Abstract][Full Text] [Related]
2. Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease--an update. Cesarini M; Fiorino G Expert Rev Clin Immunol; 2013 Apr; 9(4):301-6. PubMed ID: 23557266 [TBL] [Abstract][Full Text] [Related]
3. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease. Van Assche G; Rutgeerts P Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G169-74. PubMed ID: 15647604 [TBL] [Abstract][Full Text] [Related]
9. Targeting T and B lymphocytes in inflammatory bowel diseases: lessons from clinical trials. Gerner RR; Moschen AR; Tilg H Dig Dis; 2013; 31(3-4):328-35. PubMed ID: 24246983 [TBL] [Abstract][Full Text] [Related]
10. New therapies for inflammatory bowel disease: from the bench to the bedside. Danese S Gut; 2012 Jun; 61(6):918-32. PubMed ID: 22115827 [TBL] [Abstract][Full Text] [Related]
11. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease. Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649 [TBL] [Abstract][Full Text] [Related]
13. Novel treatment options for inflammatory bowel disease: targeting alpha 4 integrin. Lanzarotto F; Carpani M; Chaudhary R; Ghosh S Drugs; 2006; 66(9):1179-89. PubMed ID: 16827596 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of selective adhesion molecules in treatment of inflammatory bowel disease. Ghosh N; Chaki R; Mandal SC Int Rev Immunol; 2012 Oct; 31(5):410-27. PubMed ID: 23083349 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory peptides and proteins in inflammatory bowel disease. Veljaca M Curr Opin Investig Drugs; 2001 Oct; 2(10):1387-94. PubMed ID: 11890353 [TBL] [Abstract][Full Text] [Related]
16. Mathematical model of the roles of T cells in inflammatory bowel disease. Lo WC; Arsenescu RI; Friedman A Bull Math Biol; 2013 Sep; 75(9):1417-33. PubMed ID: 23760658 [TBL] [Abstract][Full Text] [Related]
17. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451 [TBL] [Abstract][Full Text] [Related]
20. Evidence for a regulatory "defect" for CD4 positive intestinal T cells in vitro in patients with IBD compared to normals. Niessner M; Gerok W; Volk BA Adv Exp Med Biol; 1995; 371B():1267-71. PubMed ID: 7502797 [No Abstract] [Full Text] [Related] [Next] [New Search]